[Oral antidiabetic agents: what are the choices?].
F M
FM
Crausaz
D000328:Adult; D001645:Biguanides / Q000009:adverse effects / Q000627:therapeutic use; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D008875:Middle Aged; D013453:Sulfonylurea Compounds / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use
D001645:Biguanides; D007004:Hypoglycemic Agents; D013453:Sulfonylurea Compounds
Antidiabétiques oraux: quel choix?